Results 241 to 250 of about 1,446,500 (314)
Autoreactive B cells in systemic lupus erythematosus: insights from integrative multi-omics analyses. [PDF]
Ushijima TS, Okamura T, Fujio K.
europepmc +1 more source
Oncofetal antigens as emerging targets in chimeric antigen receptor (CAR)-T cell-based immunotherapies: opportunities and challenges. [PDF]
Smith SS, Klampatsa A.
europepmc +1 more source
Strategic engineering B cell immunity for cancer immunotherapy. [PDF]
Li C, Venkatesh H, Trieu L, Fong L.
europepmc +1 more source
Regulatory T cell induction strategies and applications in the treatment of immune and non-immune diseases. [PDF]
Chen Y, Shi Y, You J.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Senescent Cell Antigen: A Terminal Differentiation Antigen
Survey and Synthesis of Pathology Research, 2008Investigations into mechanisms by which macrophages distinguish mature from senescent self cells revealed that a approximately 62,000 Mr glycoprotein, the senescent cell antigen, a terminal differentiation antigen, appears on the surface of senescent and damaged cells. It is recognized by the antigen-binding Fab region of a specific IgG autoantibody in
openaire +2 more sources

